MRI-Fusion Transperineal Prostate Biopsy: What It Changes, and What It Does Not

Dernière mise à jour : août 25, 2026

• WordPress
• LinkedIn
• Courrier

Prostate cancer is among the commonest cancers in men, and for decades the way of confirming it was the same: a needle passed through the wall of the rectum, sampling the prostate in a fixed pattern without knowing where any cancer actually was. Two things have changed since. They are separate changes, and they are constantly confused with one another — including in the earlier version of this article.

• Centre d'urologie Hôpital de Bangkok Thaïlande Réservation en ligne 02-310-3009 bhquro@bdms.co.th
• Hôpital Samitivej Sriracha Chonburi 088-022-1445

Two advances, doing two different jobs

• MRI targeting changes what the biopsy finds. An MRI is performed first and scored for suspicious areas. Those images are then fused with the live ultrasound during the procedure, so the needle goes to the suspicious area rather than sampling blindly. This finds more of the cancers that matter, and finds fewer of the trivial ones that would never have caused harm.
• The transperineal route changes how safe the biopsy is. The needle passes through the skin between the scrotum and the anus instead of through the rectal wall, so it does not carry bowel bacteria into the prostate and bloodstream.

They are independent. A transrectal biopsy can be MRI-targeted, and a transperineal biopsy can be done without MRI. Doing both together is the current standard, but the credit belongs where it is due.

A correction to the comparison table published here

The earlier version of this article set out a table comparing the MRI-fusion transperineal approach against the conventional transrectal approach, giving cancer detection of 81% against 40%. That comparison has been removed, for two reasons.

First, the two columns differed in two ways at once — the route et whether MRI targeting was used — so no row in the table could be attributed to either one. Second, the two figures came from two different studies of different groups of men using different definitions, and setting them side by side implied a head-to-head comparison that was never made.

What the better evidence shows is more specific, and more useful:

• MRI targeting genuinely improves detection of clinically significant cancer compared with untargeted sampling — that gain is real and it is why MRI is now done before biopsy rather than after.
• Route makes little difference to detection. Randomised trials comparing transperineal against transrectal biopsy have found broadly similar cancer detection. Choosing the transperineal route is not how you find more cancer.
• Route makes a large difference to infection, which is the honest case for it, and a strong one.

The figure of 0% for prostatitis in the old table has also gone. No procedure has a zero complication rate, and publishing one invites a confidence the numbers cannot support.

What the route actually buys you

Transperineal	Transrectal
Needle through the skin of the perineum	Needle through the rectal wall
Serious bloodstream infection is uncommon	Serious bloodstream infection is a recognised and more frequent risk, and antibiotic resistance has been making it worse
Rectal bleeding essentially avoided	Rectal bleeding common, occasionally significant
Better access to the front part of the gland, which transrectal sampling reaches poorly	Anterior tumours are more easily missed
Perineal soreness and bruising for a few days	Less perineal discomfort
Blood in the urine and semen for days to weeks	Blood in the urine and semen for days to weeks

Blood in the semen deserves a word of its own because it alarms men who were not warned: it is expected, it can look dramatic, and it can persist for several weeks. It is not a sign that anything has gone wrong.

The MRI comes first — and may spare you the biopsy

This is worth knowing before you agree to anything. The modern sequence is MRI first, biopsy second, and the scan is scored for how suspicious it looks.

Where the MRI shows nothing suspicious and the clinical picture is reassuring, it is often reasonable not to biopsy at all, and instead to follow the PSA. Men are frequently unaware this option exists. Where the MRI shows a suspicious area, the biopsy targets it — and usually takes some additional systematic samples as well, because MRI does not see everything.

Whether to have a PSA test in the first place is its own decision, discussed under should I have a PSA test.

What a biopsy cannot tell you

• A negative biopsy does not prove there is no cancer. It samples a fraction of the gland. If the PSA continues rising or the MRI remains suspicious, the question stays open.
• A positive biopsy does not always mean treatment. Some prostate cancers found this way grow so slowly that monitoring is the correct management and treating them would cause more harm than the disease. Finding cancer and needing surgery are not the same thing.
• The grade matters more than the fact. What the pathologist reports about how aggressive the cells look drives everything that follows.

If the biopsy does confirm cancer, the next conversation is about treatment — see the surgical treatment options, including robotic prostatectomy and how candidates are selected.

Symptoms after a biopsy that need attention the same day

Infection after prostate biopsy can become serious quickly. In an emergency in Thailand, call 1669.

• Fever or shaking chills — go to hospital, do not wait until morning. This is the one that matters most.
• Feeling faint, confused, or profoundly unwell.
• Inability to pass urine with a painful full bladder.
• Heavy bleeding, or clots blocking the flow.
• Increasing perineal pain and swelling after the first couple of days rather than settling.

Foire aux questions (FAQ)

What is an MRI-fusion transperineal prostate biopsy?

An MRI performed beforehand is fused with the live ultrasound image during the procedure, so the needle is directed at the suspicious area rather than sampling blindly. The needle passes through the skin of the perineum rather than through the rectal wall. The first part improves what is found; the second part reduces infection.

Does the transperineal route find more cancer?

Not by itself. Randomised comparisons have found broadly similar detection between the two routes. What improves detection is MRI targeting, which can be used with either route. An earlier version of this article implied the route was responsible for a large detection advantage, and that has been corrected.

Why choose transperineal then?

Because it avoids driving bowel bacteria into the prostate and bloodstream. Serious infection after transrectal biopsy is uncommon but real, and antibiotic resistance has made it harder to prevent. Transperineal biopsy also reaches the front of the gland better, where transrectal sampling is weakest.

Is it painful, and will I be asleep?

It can be done under local anaesthetic or under general or spinal anaesthesia, depending on the number of samples planned, your anatomy and your preference. Ask which is planned for you before the day. Afterwards, expect perineal soreness and bruising for a few days.

My MRI was normal. Do I still need a biopsy?

Often not. Where the MRI shows nothing suspicious and the clinical picture is reassuring, following the PSA rather than proceeding to biopsy is frequently a reasonable option. It is a decision to make deliberately with your urologist rather than assuming the biopsy is automatic.

If cancer is found, will I need surgery?

Not necessarily. Some prostate cancers grow slowly enough that active monitoring is the right management and treatment would do more harm than the disease. The grade reported by the pathologist, not the mere presence of cancer, determines what happens next.

Is this available in Bangkok?

Yes. Dr. Soarawee Weerasopone performs MRI-fusion transperineal prostate biopsy at Bangkok Hospital Headquarters.

Arranging a consultation

Dr. Soarawee Weerasopone sees patients at Hôpital de Bangkok Siège social and at Samitivej Sriracha Hospital in Chonburi on 088-022-1445. Bring every previous PSA result with its date, and the MRI images themselves rather than only the report.

La télémédecine de Bangkok Hospital est disponible pour les patients qui ne peuvent pas se déplacer en personne, y compris les patients internationaux — organisez-la à l'avance par e-mail auprès du service d'urologie à bhquro@bdms.co.th. Samitivej Sriracha est uniquement en personne. Les demandes concernant les coûts reçoivent une réponse de l'hôpital, et non de ce site web.

Avis de non-responsabilité : This content is written and reviewed by Dr. Soarawee Weerasopone, a board-certified urologist at Bangkok Hospital Headquarters, and is intended for education only. It is not medical advice, diagnosis or a prescription for any individual, and no advice, diagnosis or prescription is given through personal messaging channels or social media. Dr. Soarawee operates no public social media account; any account offering private consultation in his name is fraudulent. In an emergency in Thailand, call 1669.